British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half ...

UK's Haleon reported annual profit in line with market expectations on Thursday, as the Sensodyne toothpaste and Advil ...

Consumer healthcare giant Haleon has reported a strong financial performance for 2024, with organic revenue growth of five ...

Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...

Haleon has a 1-year low of $7.89 and a 1-year ... and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum ...

HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year.

Sensodyne-maker Haleon’s annual profits rose in line with expectations last year as it got a boost in demand for its oral ...

Haleon plc (NYSE: HLN) Q4 2024 Earnings Call Transcript February 27, 2025 Haleon plc misses on earnings expectations.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Haleon Pakistan has renewed its collaboration with Smile Train, the world’s largest cleft organization, to support treatment ...

Haleon projects a gradual revenue and profit ... The company, which makes Sensodyne toothpaste, ENO antacids and Centrum multivitamins, projected organic revenue would grow between 4 per cent ...